Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Director/PDMR Shareholding

10 Mar 2010 07:00

RNS Number : 3365I
Imaginatik PLC
10 March 2010
 



10 March 2010

Imaginatik plc

("Imaginatik" or the "Company")

 

Directors' Shareholding

 

Imaginatik plc (AIM: IMTK), a provider of collaborative innovation software and processes, announces that it was notified yesterday that on the same day, Matt Cooper, Non-Executive Chairman of the Company, purchased 1 million ordinary shares of 0.0625 pence each in the Company ("Ordinary Shares") from Mark Turrell, Chief Executive Officer of the Company, at a price of 4 pence per Ordinary Share.

 

Following this transaction, Mr Turrell's beneficial interest in the Company (including the Ordinary Shares of his wife, Dr Yvonne Lindow) is 76,819,415 Ordinary Shares, representing 48.25 per cent. of the issued share capital of the Company, and Mr Cooper's holding is 1,478, 588 Ordinary Shares, representing 0.92 per cent. of the issued share capital of the Company.

 

Matt Cooper, Chairman of Imaginatik plc commented, "Imaginatik has proven its ability to solve problems for some of the world's largest companies, harnessing the brain power of their thousands of employees in a manner previously impossible without the use of sophisticated technology. Having been in this space for over a decade, Imaginatik is a leader in its market and as the industry around it gains momentum, so its opportunity continues to grow."

 

 

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

ICIS

Tel: 020 7651 8688

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

 

Imaginatik is a leading provider of Collective Intelligence solutions, including Collaborative Innovation, Open Innovation and Idea Management technology and services. Some of the world's leading companies use Imaginatik's Idea Central software platform to identify and develop the important ideas and strategies that will drive the future of their business. For more than 10 years, Imaginatik has helped customers including CSC, Pfizer, Boeing, Chubb and Cargill achieve outstanding results with the experience of its consulting team and highly configurable web-based software.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London, UK. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte. Imaginatik is committed to ongoing research into the nature of human networks, innovation and collective intelligence. The Company collaborates with several academic institutions including the IXL Center at Hult International Business School.

 

For further information please visit http://www.imaginatik.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSJLMLTMBIMBLM
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.